Clinical Scorecard: Epidemiological Insights and Neonatal Outcomes of Patent Ductus Arteriosus Following Transcatheter Closure: A Retrospective Analysis from Qatar
At a Glance
Category
Detail
Condition
Patent Ductus Arteriosus (PDA)
Key Mechanisms
Failure of the ductus arteriosus to close after birth, leading to a left-to-right shunt.
Target Population
Preterm infants diagnosed with PDA.
Care Setting
Tertiary referral center managing complex cases.
Key Highlights
Transcatheter device closure was performed in 65% of patients.
86.5% implant success rate on the first attempt for transcatheter closure.
Gestational age <37 weeks significantly associated with catheter-based treatment.
Device embolization occurred in 4 patients during the procedure.
Non-procedure-related mortality was 9.6%.
Guideline-Based Recommendations
Diagnosis
Diagnosis of PDA is based on clinical presentation and echocardiographic findings.
Management
Management options include pharmacological treatment and transcatheter closure for hemodynamically significant PDAs.
Monitoring & Follow-up
Patients should be monitored for complications such as residual shunt and device embolization.
Risks
Risks include device embolization, vascular injury, and potential reopening of PDA post-treatment.
Patient & Prescribing Data
Infants diagnosed with PDA at Sidra Medicine, Qatar.
Transcatheter closure is a viable option with high success rates in preterm infants.
Clinical Best Practices
Consider gestational age and PDA characteristics when selecting treatment options.
Utilize transcatheter closure as a first-line intervention for significant PDAs in preterm infants.
